133 related articles for article (PubMed ID: 14767552)
1. Increased expression of IGF II mRNA-binding protein 1 mRNA is associated with an advanced clinical stage and poor prognosis in patients with ovarian cancer.
Gu L; Shigemasa K; Ohama K
Int J Oncol; 2004 Mar; 24(3):671-8. PubMed ID: 14767552
[TBL] [Abstract][Full Text] [Related]
2. Human kallikrein gene 11 (KLK11) mRNA overexpression is associated with poor prognosis in patients with epithelial ovarian cancer.
Shigemasa K; Gu L; Tanimoto H; O'Brien TJ; Ohama K
Clin Cancer Res; 2004 Apr; 10(8):2766-70. PubMed ID: 15102682
[TBL] [Abstract][Full Text] [Related]
3. Skp2 overexpression is a prognostic factor in patients with ovarian adenocarcinoma.
Shigemasa K; Gu L; O'Brien TJ; Ohama K
Clin Cancer Res; 2003 May; 9(5):1756-63. PubMed ID: 12738731
[TBL] [Abstract][Full Text] [Related]
4. Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer.
Kusuda T; Shigemasa K; Arihiro K; Fujii T; Nagai N; Ohama K
Oncol Rep; 2005 Jun; 13(6):1153-8. PubMed ID: 15870936
[TBL] [Abstract][Full Text] [Related]
5. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K
Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
[TBL] [Abstract][Full Text] [Related]
6. Increased MCL-1 expression is associated with poor prognosis in ovarian carcinomas.
Shigemasa K; Katoh O; Shiroyama Y; Mihara S; Mukai K; Nagai N; Ohama K
Jpn J Cancer Res; 2002 May; 93(5):542-50. PubMed ID: 12036450
[TBL] [Abstract][Full Text] [Related]
7. Underexpression of cyclin-dependent kinase inhibitor p27 is associated with poor prognosis in serous ovarian carcinomas.
Shigemasa K; Shiroyama Y; Sawasaki T; Fujii T; Nagai N; Parmley TH; O'Brien TJ; Ohama K
Int J Oncol; 2001 May; 18(5):953-8. PubMed ID: 11295040
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.
Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L
Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797
[TBL] [Abstract][Full Text] [Related]
9. Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival.
Sun F; Ding W; He JH; Wang XJ; Ma ZB; Li YF
BMC Cancer; 2015 Oct; 15():746. PubMed ID: 26487491
[TBL] [Abstract][Full Text] [Related]
10. PRSS3 expression is associated with tumor progression and poor prognosis in epithelial ovarian cancer.
Ma R; Ye X; Cheng H; Ma Y; Cui H; Chang X
Gynecol Oncol; 2015 Jun; 137(3):546-52. PubMed ID: 25735255
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of CD44 expression in ovarian epithelial tumors].
Qu P; Jiao S; Gao Q
Zhonghua Zhong Liu Za Zhi; 2001 Jan; 23(1):46-9. PubMed ID: 11783069
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of insulin-like growth factor-II messenger RNA-binding protein 1 is associated with tumor progression in patients with lung cancer.
Kato T; Hayama S; Yamabuki T; Ishikawa N; Miyamoto M; Ito T; Tsuchiya E; Kondo S; Nakamura Y; Daigo Y
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):434-42. PubMed ID: 17255263
[TBL] [Abstract][Full Text] [Related]
13. NEDD9 overexpression is associated with the progression of and an unfavorable prognosis in epithelial ovarian cancer.
Wang H; Mu X; Zhou S; Zhang J; Dai J; Tang L; Xiao L; Duan Z; Jia L; Chen S
Hum Pathol; 2014 Feb; 45(2):401-8. PubMed ID: 24439227
[TBL] [Abstract][Full Text] [Related]
14. PEA3 is the second Ets family transcription factor involved in tumor progression in ovarian carcinoma.
Davidson B; Goldberg I; Gotlieb WH; Kopolovic J; Ben-Baruch G; Reich R
Clin Cancer Res; 2003 Apr; 9(4):1412-9. PubMed ID: 12684413
[TBL] [Abstract][Full Text] [Related]
15. Multivariate analysis by Cox proportional hazard model on prognosis of patient with epithelial ovarian cancer.
Wang M; He Y; Shi L; Shi C
Eur J Gynaecol Oncol; 2011; 32(2):171-7. PubMed ID: 21614907
[TBL] [Abstract][Full Text] [Related]
16. KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.
White NM; Mathews M; Yousef GM; Prizada A; Popadiuk C; Doré JJ
Br J Cancer; 2009 Oct; 101(7):1107-13. PubMed ID: 19707197
[TBL] [Abstract][Full Text] [Related]
17. p27Kip1 expression is associated with clinical outcome in advanced epithelial ovarian cancer: multivariate analysis.
Masciullo V; Ferrandina G; Pucci B; Fanfani F; Lovergine S; Palazzo J; Zannoni G; Mancuso S; Scambia G; Giordano A
Clin Cancer Res; 2000 Dec; 6(12):4816-22. PubMed ID: 11156240
[TBL] [Abstract][Full Text] [Related]
18. Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma.
Davidson B; Reich R; Goldberg I; Gotlieb WH; Kopolovic J; Berner A; Ben-Baruch G; Bryne M; Nesland JM
Clin Cancer Res; 2001 Mar; 7(3):551-7. PubMed ID: 11297247
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the cyclin-dependent kinase inhibitor p21Cip1 in epithelial ovarian tumors of low malignant potential and adenocarcinomas.
Vassilopoulos I; Korkolopoulou P; Konstantinidou AE; Patsouris E; Eftichiadis C; Thymara I; Perdiki M; Pavlakis K; Agapitos E; Davaris PS
Histol Histopathol; 2003 Jul; 18(3):761-70. PubMed ID: 12792888
[TBL] [Abstract][Full Text] [Related]
20. Sam68 is Overexpressed in Epithelial Ovarian Cancer and Promotes Tumor Cell Proliferation.
Dong L; Che H; Li M; Li X
Med Sci Monit; 2016 Sep; 22():3248-56. PubMed ID: 27623016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]